HighTower Advisors’s Comera Life Sciences Holdings, Inc. Common Stock CMRA Stock Holding History

HighTower Advisors’s Portfolio CMRA Stock Details CMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-47,600	Closed	-$14K	–	3912
2023 Q3	$14K	Hold	47,600	–	–	﹤0.01%	3362
2023 Q2	$23K	Hold	47,600	–	–	﹤0.01%	3243
2023 Q1	$43K	Hold	47,600	–	–	﹤0.01%	3065
2022 Q4	$59K	Hold	47,600	–	–	﹤0.01%	3007
2022 Q3	$77K	Buy	+47,600	New	+$114K	﹤0.01%	2820

HighTower Advisors's CMRA Position: Q4 2023 in Review

HighTower Advisors sold out of Comera Life Sciences Holdings, Inc. Common Stock (CMRA) in Q4 2023, closing a stake of 47,600 shares — an estimated $14K sold.

HighTower Advisors first reported a position in CMRA in Q3 2022 and held it in 5 quarters. The position peaked at $77K in Q3 2022. 0 funds tracked by Wall St. Rank hold CMRA as of Q4 2023.

HighTower Advisors reported no remaining Comera Life Sciences Holdings, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
HighTower Advisors sold 47,600 Comera Life Sciences Holdings, Inc. Common Stock shares in Q4 2023, an estimated $14K.
HighTower Advisors first reported a position in Comera Life Sciences Holdings, Inc. Common Stock in Q3 2022 and held it in 5 quarters.
HighTower Advisors's Comera Life Sciences Holdings, Inc. Common Stock position peaked at $77K in Q3 2022.
0 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Common Stock as of Q4 2023.

Based on HighTower Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.